Estimating Hypothetically Negotiated Royalty Rates After MedImmune, Inc. v Genentech, Inc. et al
$25.00v14i3: pp. 43-52 Stenan D. Porter Antitrust 2008
Showing the single result
Showing the single result
v14i3: pp. 43-52 Stenan D. Porter Antitrust 2008
Problems with the use of periodic payments in actions against health care providers
1 × $25.00 Wrongful Death: Who Recovers What, Where, and How?
1 × $25.00 Subtotal: $50.00